Navigation Links
RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
Date:7/14/2010

LAKE FOREST, Ill., July 14 /PRNewswire/ -- RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Bioniche Pharma Holdings Limited ("Bioniche Pharma") to Mylan Inc. ("Mylan"), a leading, global generic and specialty pharmaceutical company, for $550 million in cash.  The closing is conditional on regulatory approval and other customary closing conditions.

Bioniche Pharma is a fully-integrated, global specialty sterile injectable pharmaceutical company based in Ireland with a majority of its sales in the United States.  RoundTable acquired a majority interest in the company in February 2006.  The ICC Private Equity Fund managed by the Venture Capital Division of Bank of Scotland (Ireland) Ltd. is selling its minority shareholding in Bioniche Pharma as part of the transaction.  Bioniche Pharma's revenue increased six-fold during RoundTable's investment period.

"Bioniche Pharma's exceptional management team and dedicated employees have driven the company to become a leading, generic and specialty injectable pharmaceutical company," said Jack McGinley, a Founding Partner of RoundTable and the Chairman of the Board of Bioniche Pharma.  "We believe Mylan is an excellent strategic partner for the company, its employees and customers going forward."

"RoundTable has been an ideal partner for Bioniche Pharma," said Steve Thornton, CEO of Bioniche Pharma.  "They have supported substantial investments in our employees, research and development, facilities and business development activities.  Their operating and transaction teams' relationships, guidance and resources have been instrumental to achieving our success."

"RoundTable has been an excellent, valued-added partner in our Bioniche Pharma investment, and we congratulate the management team and employees in building a strong company," said Pat McGrath, Director, Venture Capital of Bank of Scotland (Ireland) Ltd. and Board Director of Bioniche Pharma.

Deutsche Bank Securities Inc. acted as exclusive financial advisor to Bioniche Pharma.  Kirkland & Ellis LLP acted as lead legal counsel, and Beauchamps Solicitors served as Irish legal counsel to RoundTable.

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry.  RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.  RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model.  RoundTable currently manages $1.1 billion in capital, including two equity funds totaling $900 million and a subordinated debt fund of $200 million.  More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.  


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Justice Department Will Not Oppose CEO Roundtable on Cancers Proposal
3. Roundtable Calls Presidents Embryonic Stem Cell Decision: Bankrupt
4. BARC Central Laboratory Joins Alzheimers Association Research Roundtable
5. RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation
6. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Microplate Instrumentation ... ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. Annual ... a six-year historic analysis is provided for these markets. Market data and ...
(Date:3/24/2017)... 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today disclosed ... Term Sheet (the "Definitive Financing") it entered into ... Company,s stockholders, who are referred to in the ... 8-K filed with the Securities and Exchange Commission. ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination ... are complicated and require expert user knowledge. In a live webinar on April ... the simplified, yet highly accurate, determination of sodium. , It has long been ...
(Date:3/27/2017)... Irvine, CA (PRWEB) , ... March 27, 2017 ... ... company has entered a settlement agreement to resolve the pending litigation between itself ... Court for the District of Utah). , “I am thrilled to announce that ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Harris Communications, Inc., ... hearing, is bringing its latest products to the Deaf Seniors of America Conference, April ... the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and to ...
Breaking Medicine News(10 mins):